InsiderClue
Insiders · Profile

Fust Matthew K

Director at Crinetics Pharmaceuticals · Director at Neumora Therapeutics · Director at Ultragenyx Pharmaceutical · and 2 more. Filing since 30 Jan 2014. CIK 0001397266

CRNX Crinetics Pharmaceuticals, Inc. Director · 9 trades NMRA Neumora Therapeutics, Inc. Director · 2 trades RARE Ultragenyx Pharmaceutical Inc. Director · 7 trades ATRA Atara Biotherapeutics, Inc. Director · 2 trades MGNX MACROGENICS INC Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
CRNX Crinetics Pharmaceuticals, Inc.
26 Sep 2025
Director
Sold on a plan
16,000
$716.00K
41.2%
NMRA Neumora Therapeutics, Inc.
18 Oct 2024
Director
Sold on a plan
14,049
$239.32K
41.1%
NMRA Neumora Therapeutics, Inc.
17 Oct 2024
Director
Sold on a plan
7,739
$131.64K
27.8%
CRNX Crinetics Pharmaceuticals, Inc.
20 Mar 2024
Director
Sold on a plan
60,000
$2.65M
76.4%
RARE Ultragenyx Pharmaceutical Inc.
7 Mar 2024
Director
Sold on a plan
12,195
$620.44K
45.1%
CRNX Crinetics Pharmaceuticals, Inc.
13 Jul 2022
Director
Sold, plan not stated
5,700
$119.45K
31.3%
ATRA Atara Biotherapeutics, Inc.
4 Nov 2021
Director
Sold, plan not stated
13,354
$260.40K
29.8%
CRNX Crinetics Pharmaceuticals, Inc.
1 Nov 2021
Director
Sold, plan not stated
8,954
$228.33K
41.7%
CRNX Crinetics Pharmaceuticals, Inc.
8 Sep 2021
Director
Sold, plan not stated
6,046
$154.17K
32.5%
CRNX Crinetics Pharmaceuticals, Inc.
26 Jul 2021
Director
Sold, plan not stated
5,000
$97.95K
28.5%
CRNX Crinetics Pharmaceuticals, Inc.
19 Jul 2021
Director
Sold, plan not stated
5,000
$97.50K
28.5%
CRNX Crinetics Pharmaceuticals, Inc.
12 Jul 2021
Director
Sold, plan not stated
5,000
$103.55K
28.5%
RARE Ultragenyx Pharmaceutical Inc.
6 Jul 2020
Director
Sold, plan not stated
6,181
$556.29K
31.3%
RARE Ultragenyx Pharmaceutical Inc.
1 Jul 2020
Director
Sold, plan not stated
5,000
$425.00K
27.0%
RARE Ultragenyx Pharmaceutical Inc.
18 May 2020
Director
Sold, plan not stated
1,875
$140.63K
14.6%
RARE Ultragenyx Pharmaceutical Inc.
22 Apr 2020
Director
Sold, plan not stated
1,875
$121.88K
12.7%
CRNX Crinetics Pharmaceuticals, Inc.
16 Dec 2019
Director
Sold, plan not stated
3,500
$78.75K
21.8%
MGNX MACROGENICS INC
6 Feb 2019
Director
Sold, plan not stated
6,924
$203.43K
93.3%
RARE Ultragenyx Pharmaceutical Inc.
30 May 2018
Director
Sold, plan not stated
6,319
$454.97K
41.9%
ATRA Atara Biotherapeutics, Inc.
14 May 2018
Director
Sold, plan not stated
12,286
$535.30K
38.3%
RARE Ultragenyx Pharmaceutical Inc.
30 Jan 2014
Director
Bought
5,000
$105.00K
opened
21 decisions on file.